Pharma Journalist 7836 posts 0 comments

Alphaeon announced that it has submitted a BLA (biologic license application) for the Daewoong Botulinum toxin Type A, with the USFDA seeking approval for the treatment of adult…
Read More...

An article published in Experimental Biology and Medicine (Volume 242, Issue 10, May, 2017) identifies a new treatment that may protect the brain from irreversible damage caused by…
Read More...

Maxor National Pharmacy Services announced that Vertex Pharmaceuticals has now included Maxor Specialty in its specialty pharmacy network with immediate effects. Patients may now…
Read More...

Center for Drug Evaluation under China FDA announced that rice-extracted human blood protein is "safe and effective," and its quality can be easily controlled. The Chinese FDA has also…
Read More...

Albireo Pharma announced that USPTO (United States Patent and Trademark Office) has allowed U.S. Patent Application No. 15/276,446, “IBAT inhibitors for the treatment of liver diseases”…
Read More...

Avenue Therapeutics announced that it has received Notice of Allowance from USPTO (U.S. Patent and Trademark Office) for a new patent application (U.S. Application No. 15/163,111),…
Read More...

Greater Than One (GTO) has appointed Kieran Walsh as President of its US operations with immediate effects. Walsh will be responsible for leading the GTO staff and offices in New York…
Read More...

MSD President, Jannie Oosthuizen and Astellas Pharma President and CEO, Yoshihiko Hatanaka together announced that MSD has submitted an application for marketing approval of a…
Read More...

Acasti Pharma announced that it has received an invitation to present the CaPre (omega-3 phospholipid) study results at the National Lipid Association Scientific Sessions in…
Read More...

XOMA Corporation announced it has earned a $10 million milestone payment as one Company asset licensed to one of its pharmaceutical partners advances into clinical development. XOMA…
Read More...